Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED
暂无分享,去创建一个
[1] Stephen Duffull,et al. Modeling and Simulation for Clinical Trial Design Involving a Categorical Response: A Phase II Case Study with Naratriptan , 2001, Pharmaceutical Research.
[2] L B Sheiner,et al. Quantitative characterization of therapeutic index: Application of mixed‐effects modeling to evaluate oxybutynin dose–efficacy and dose–side effect relationships , 1999, Clinical pharmacology and therapeutics.
[3] N H Holford,et al. Simulation of clinical trials. , 2000, Annual review of pharmacology and toxicology.
[4] Lynn McFadyen,et al. A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[5] J. Ware,et al. Random-effects models for serial observations with binary response. , 1984, Biometrics.
[6] J Wakefield,et al. A population approach to initial dose selection. , 1997, Statistics in medicine.
[7] Noreen Goldman,et al. An assessment of estimation procedures for multilevel models with binary responses , 1995 .
[8] Sylvie Chabaud,et al. Clinical Trial Simulation Using Therapeutic Effect Modeling: Application to Ivabradine Efficacy in Patients with Angina Pectoris , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[9] Robert W. Mee,et al. A mixed-model procedure for analyzing ordered categorical data , 1984 .
[10] A. Agresti. Modelling ordered categorical data: recent advances and future challenges. , 1999, Statistics in medicine.
[11] D. Bates,et al. Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .
[12] L B Sheiner,et al. A new approach to the analysis of analgesic drug trials, illustrated with bromfenac data , 1994, Clinical pharmacology and therapeutics.
[13] D. Mould,et al. Population pharmacokinetic and adverse event analysis of topotecan in patients with solid tumors , 2002, Clinical pharmacology and therapeutics.
[14] Mats O. Karlsson,et al. Assumption Testing in Population Pharmacokinetic Models: Illustrated with an Analysis of Moxonidine Data from Congestive Heart Failure Patients , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[15] D R Stanski,et al. Population pharmacodynamic model for ketorolac analgesia , 1996, Clinical pharmacology and therapeutics.
[16] S Senn,et al. A random effects model for ordinal responses from a crossover trial. , 1991, Statistics in medicine.
[17] L. Aarons,et al. Methodological approaches to the population analysis of toxicity data. , 2001, Toxicology letters.
[18] J Wakefield,et al. Cumulative logit models for ordinal data: a case study involving allergic rhinitis severity scores , 2001, Statistics in medicine.
[19] J. DeJongh,et al. Population pharmacokinetic and pharmacodynamic modeling of propofol for long‐term sedation in critically ill patients: A comparison between propofol 6% and propofol 1% , 2002, Clinical pharmacology and therapeutics.
[20] N. Breslow,et al. Bias Correction in Generalized Linear Mixed Models with Multiple Components of Dispersion , 1996 .